From right to left: Steve Posnack, principal deputy secretary, ASTP/ONC; Carolyn Clancy, deputy under secretary for health, VA; Grace Cordovano, patient-in-residence, DiMe Building a better healthcare ...

Virtual specialty care platform AmplifyMD, which aims to help hospitals do more with fewer doctors, scored $20 million dollars this Wednesday in a Series B financing round led by Forerunner Ventures.

A uniQure gene therapy slowed progression of Huntington’s disease by 75% after three years, statistically significant clinical trial results the company says will support plans for a regulatory ...

Capital Rx, a transparent pharmacy benefit manager, has secured a $400 million investment and is rebranding under the name Judi Health as it expands beyond pharmacy benefits, the company announced on ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...

The U.S. Food & Drug Administration (FDA) recently removed its Risk Evaluation and Mitigation Strategies (REMS) designation from CAR T immunotherapies. REMS is occasionally applied to drugs with ...

During the MedCity INVEST Digital Health conference in Dallas, three executives shared what’s top of mind as they deploy AI in the healthcare workforce, including the need to build trust and improve ...

In rural America, virtual care often means the difference between care and no care. Few people know this to be true more than Dave Newman, chief medical officer of virtual care at Sanford Health. For ...

During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they're looking for from AI startups and what their red flags are.

Duke University Health System is deploying a mix of homegrown and purchased AI tools to ease clinicians’ administrative burden and improve patient care. Chief Nurse Executive Terry McDonnell ...